Recent advances and novel approaches in laboratory-based diagnostic mycology

• Published in: Medical mycology (Oxford) Vol. 57; no. Supplement_3; pp. S259 - S266
• Main Author: White, P Lewis
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01-06-2019
• Subjects: risk stratification; proximity ligation assay; fungi; lateral flow assay; next generation sequencing; T2; T2 Candida
• ISSN: 1369-3786; 1460-2709
• DOI: 10.1093/mmy/myy159

Abstract
The field of diagnostic mycology represents much more than culture and microscopy and is rapidly embracing novel techniques and strategies to help overcome the limitations of conventional approaches. Commercial molecular assays increase the applicability of PCR testing and may identify markers of antifungal resistance, which are of great clinical concern. Lateral flow assays simplify testing and turn-around time, with potential for point of care testing, while proximity ligation assays embrace the sensitivity of molecular testing with the specificity of antibody detection. The first evidence of patient risk stratification is being described and together with the era of next generation sequencing represents an exciting time in mycology.